Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heparan sulfate glycosaminoglycans (HS GAGs) are complex, linear polysaccharides found on cell surfaces and in the extracellular matrix, where they play a fundamental role in regulating cell signaling and homeostasis (Gallagher, 2015, J. Histochem. Cytochem.). The N-sulfate groups, which are added to glucosamine residues by N-deacetylase/N-sulfotransferase (NDST) enzymes, are the primary structural determinants for protein binding (Xu & Esko, 2014, Annu. Rev. Biochem.). These groups form highly negatively charged "S-domains" that interact with hundreds of extracellular proteins, including growth factors, chemokines, and morphogens, thereby modulating their stability and activity (Bishop et al., 2007, Nature). In clinical practice, these N-sulfated regions are the functional targets for heparin and low-molecular-weight heparins, which bind to antithrombin III to exert anticoagulant effects (Linhardt, 2003, J. Med. Chem.). Beyond coagulation, N-sulfate groups are exploited by various pathogens, such as SARS-CoV-2 and Herpes Simplex Virus, as initial attachment sites for host cell entry (Clausen et al., 2020, Cell). They also contribute to tumor progression by facilitating angiogenesis and protecting growth factors from proteolysis, making them attractive targets for heparin mimetics and other glycan-focused therapeutics (Dreyfuss et al., 2009, Biomolecules).
Drugs targeting these groups function by mimicking the sulfation patterns to bind and modulate the activity of proteins like antithrombin III, or by competitively blocking the interaction between the N-sulfate groups and their physiological or pathological ligands, such as growth factors or viral proteins (Linhardt, 2003, J. Med. Chem.; Clausen et al., 2020, Cell).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heparan sulfate glycosaminoglycan N-sulfate group (HS-NS).